Bio-based Food Ingredients Market Size, Share, and Growth Forecast 2026 - 2033

The global bio-based food ingredients market size is likely to be valued at US$38.4 billion in 2026 and is estimated to reach US$68.4 billion by 2033, growing at a CAGR of 8.6% during the forecast period from 2026 to 2033, driven by rising demand for clean-label products and surging use of fermentation-derived ingredients. Expanding regulatory clearances are also helping new ingredients reach the market.

Driver - Clean-label and Sustainability Demand to Push Bio-based Substitution

Food brands want ingredients that are renewable, traceable, and easy to explain. Bio-based ingredients meet this need as they come from plants, microbes, and other biological sources. They can replace synthetic additives and fossil-derived inputs. A U.S. Department of Agriculture (USDA) analysis found that biobased products added US$489 billion in value to the U.S. economy in 2021. The sector employed 3.94 million people and displaced about 10.7 million barrels of oil a year.

Policy is reinforcing this shift. Germany's National Bioeconomy Strategy, adopted in January 2020, aims to cut reliance on fossil resources and covers the food industry. Consumers are also open to new sources. The HealthFerm project found in 2024 that 52% of consumers in nine European countries were willing to try precision-fermentation products.

Regulatory Clearances to Strengthen Commercial Pathways

Clearances are turning pilot ingredients into commercial products. In June 2026, the European Commission authorized The Protein Brewery's Fermotein as a novel food. In July 2026, Health Canada issued a Letter of No Objection for BMC Ingredients' Rhiza mycoprotein. These approvals show that regulators are building clear routes for fermentation-derived foods. Fermotein had already been cleared in Singapore.

Asia is moving as well. China's National Health Commission approved 18 new food additives and related items in the first half of 2026. They included human milk oligosaccharides and food enzymes. Each clearance reduces uncertainty for ingredient makers and encourages investment in new capacity.

Restraint- Slow Approvals and Scale-up Costs May Limit Market Entry

Approval timelines remain a major barrier, especially in Europe. In December 2025, the EU Biotech Act proposal expanded European Food Safety Authority (EFSA) guidance for precision fermentation applicants. However, it excluded novel foods from regulatory sandboxes. GFI Europe also says the biggest bottleneck is the lack of large-scale fermentation facilities in the region. EFSA assessments apply across all 27 member states, but the process is long. The Protein Brewery first filed more than five years before its 2025 EFSA opinion.

Compliance is also becoming stricter in the U.S. The FDA's August 2026 proposal would replace voluntary GRAS notification with a mandatory system. The agency says it is not a premarket review program. Even so, companies would need to document and notify their safety conclusions. Small developers may face higher legal and data costs. In March 2025, the Department of Health and Human Services had asked FDA to explore eliminating self-affirmed GRAS.

Opportunity- Fermentation-derived Proteins to Open Animal-free Applications

Fermentation-derived proteins can supply functional nutrition without livestock. Fermotein is made from the fungus Rhizomucor pusillus and is positioned for active nutrition and snacking. EFSA found no safety or genotoxicity concerns and confirmed low allergenicity. The company produces it at a pilot plant in Breda that makes 100 kg daily.

Scale is the next test. The Protein Brewery raised a US$35 million Series B in September 2025 and about US$60 million in total. Rhiza mycoprotein, made by fermenting Neurospora crassa, has now reached its third market in Canada. Larger plants and lower costs will decide how fast these proteins move beyond niche products.

Biomanufactured Sweeteners and Oligosaccharides to Create Premium Niches

Biomanufacturing is also expanding in sweeteners and prebiotics. China's 2026 approvals included 3'-SL, a human milk oligosaccharide, and D-allulose 3-epimerase, an enzyme. The CIRS Group noted that oligosaccharides, new food enzymes, and natural sweeteners accounted for a significant share of applications and approvals.

These ingredients support sugar reduction and gut health claims. They also command premium pricing in infant, medical, and sports nutrition. China also issued supplementary quality specifications for 2'-FL and LNnT, which shows steady regulatory attention to oligosaccharides. Producers that secure approvals in several regions can build durable positions.

Ingredient Type Insights

Sweeteners and carbohydrates are predicted to lead with a share of about 33.8% in 2026, as they serve almost every food and beverage category. This group covers starches, syrups, natural sweeteners, and rare sugars. Brands are replacing refined sugar and synthetic sweeteners with bio-based options. Enzymatic and fermentation routes also widen the choice of rare sugars.

Proteins are estimated to be the fastest-growing type over the forecast period, as fermentation and fungal biomass open new supply routes. Fermotein and Rhiza mycoprotein show how new proteins are moving through regulatory systems. Demand also comes from active nutrition, GLP-1 users, and meat and dairy alternatives. Cost and scale remain the main hurdles.

Source Insights

Plant-based sources are anticipated to dominate with a share of around 61.5% in 2026, as crops provide large, low-cost, and familiar raw materials. Processors already operate extraction, milling, and refining systems at scale. In August 2026, Ingredion's carrot-derived prebiotic Benicaros SF Pure P was authorized as a novel food in the EU. Such launches keep plant-based ingredients at the center of the market.

Microbial sources are expected to be the fastest-growing source over the forecast period, as fermentation delivers consistent quality without heavy land use. Rhiza, for example, is made by fermenting Neurospora crassa. Fungal and bacterial processes can produce proteins, enzymes, and oligosaccharides. Regulatory approvals are beginning to follow. Capacity and cost will shape adoption.

North America Bio-based Food Ingredients Market Trends

North America is predicted to dominate in 2026 globally with a share of approximately 36.8%, supported by a deep ingredient manufacturing base, an established GRAS pathway, and early commercial launches. The USDA's 2023 update found that biobased products employed 3.94 million people in 2021. Each job supported another 1.4 jobs in other sectors. Canada's approval of Rhiza adds to regional momentum.

U.S. Bio-based Food Ingredients Market Trends

A share of nearly 84.2% is expected to be held by the U.S. in 2026 in North America, as it has large ingredient producers and a broad food manufacturing sector. The FDA announced its mandatory GRAS proposal in August 2026. It includes a 120-day public comment period. FDA says companies could keep marketing a substance while their notice is reviewed. Industry experts quoted by NutraIngredients said FDA now receives roughly 50 voluntary GRAS notices a year. A mandatory system could raise that number sharply. Secretary Robert F. Kennedy Jr. estimated that 4,000 to 12,000 ingredients are in the food supply, and FDA could not give a precise count.

Asia Pacific Bio-based Food Ingredients Market Trends

Asia Pacific is anticipated to be the fastest-growing region globally in 2026 with a share of around 28.9%. It combines a large food manufacturing base, rising demand for functional nutrition, and active regulators. New ingredient approvals and labeling rules are shaping product development across the region.

China Bio-based Food Ingredients Market Trends

China will likely lead in Asia Pacific in 2026 with a share of about 41.6%. The National Health Commission approved 18 new food additives and related items in the first half of 2026, across two announcements. These included 3'-SL, D-allulose 3-epimerase, xylanase, and cellulase. Approvals of oligosaccharides, enzymes, and natural sweeteners point to rising biomanufacturing activity.

India Bio-based Food Ingredients Market Trends

In 2026, India is projected to account for a share of just about 11.8% in Asia Pacific, as it has a large vegetarian consumer base and a growing packaged food sector. The Food Safety and Standards Authority of India (FSSAI) notified the Vegan Foods Amendment Regulations on May 25, 2026. They take effect on July 1, 2027 and require a standard vegan logo. This can raise demand for verified plant-based ingredients. A draft was issued in December 2022, followed by a 60-day objection period. Imported products and e-commerce listings are covered.

Europe Bio-based Food Ingredients Market Trends

Europe will likely witness steady growth over the forecast period with a share of roughly 14.6% in 2026 globally, due to strong sustainability policy and advanced fermentation research. Approvals are still slow. EFSA gave Fermotein a positive opinion in 2025, and the European Commission authorized it in June 2026. The EU Biotech Act proposal, published in December 2025, did not include novel foods in its sandboxes. An EIT Food survey found that 43% of respondents in six countries would try precision-fermented dairy.

Germany Bio-based Food Ingredients Market Trends

Germany is predicted to register a substantial share of approximately 26.4% in 2026 in Europe, as it has a large food industry and a long-standing bioeconomy policy. The Cabinet adopted the national strategy on January 15, 2020. It treats plants, animals, and microorganisms as biological resources. GFI Europe and Accenture research found that about half of consumers in France, Germany, and Spain would try precision-fermented dairy or egg products if offered a free sample. Around one in five would add them to their diet.

U.K. Bio-based Food Ingredients Market Trends

A share of nearly 15.9% is predicted to be held by the U.K. in Europe in 2026. The Food Standards Agency announced reforms in September 2024 to speed up novel food approvals. Approvals averaged two and a half years. A new public register would remove a Statutory Instrument step that adds up to six months. The reforms also end reauthorization of products already judged safe. All new products still undergo safety and nutritional assessment, and ministers keep final approval.

The global bio-based food ingredients market is fragmented, with large ingredient processors competing alongside fermentation start-ups. Ingredion, Cargill, Archer-Daniels-Midland, Kerry Group, and Tate & Lyle hold broad portfolios in starches, sweeteners, fibers, and texturizers. Start-ups such as The Protein Brewery, Perfect Day, The EVERY Company, and Oobli are building new protein and sweetener platforms.

Competition is shifting from basic supply toward regulatory readiness and scale. Impossible Foods, Perfect Day, and The EVERY Company obtained U.S. GRAS notices for fermentation-derived proteins between 2018 and 2021. Europe has been slower to clear similar proteins. Incumbents are moving too, as Ingredion's Benicaros SF Pure P shows in novel prebiotics. Companies with approvals in several regions and access to large fermentation capacity are better placed to win long-term supply contracts.

Key Industry Developments:

• In July 2026, ADM announced a collaboration with The EVERY Company to begin commercial-scale production of OvoPro, a precision-fermentation-derived egg-white protein, at ADM's facility in Clinton, Iowa. The partnership aims to expand production capacity and meet demand for functional protein ingredients used in food applications. OvoPro provides binding, gelling, foaming, and whipping properties, offering food manufacturers an alternative to conventional egg-white ingredients.
• In June 2026, Ingredion announced its acquisition of Benicaros, a patented prebiotic fiber produced from upcycled carrot pomace. The acquisition included the product's intellectual property, trademarks, human clinical trial data, and manufacturing know-how. The ingredient is designed to support immune health through its effects on beneficial gut bacteria and can be incorporated into functional foods and beverages, expanding Ingredion's portfolio of plant-based, upcycled functional ingredients.
• In May 2026, Tate & Lyle announced an expansion of its collaboration with BioHarvest Sciences to develop multiple plant-based sweetener molecules. Building on an initial agreement signed in 2024, the expanded program aims to broaden the range of sweetening solutions available to food and beverage manufacturers. The initiative focuses on developing ingredients that can address different formulation requirements, including taste, cost, and labelling considerations.